Invention Grant
- Patent Title: EGFR and C-Met fibronectin type III domain binding molecules
-
Application No.: US14086250Application Date: 2013-11-21
-
Publication No.: US09725497B2Publication Date: 2017-08-08
- Inventor: Mark Anderson , Ricardo Attar , Michael Diem , Linus Hyun , Steven Jacobs , Alastair King , Donna Klein , Sheri Moores , Karyn O'Neil , Kristen Picha
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agent Eric Dichter
- Main IPC: C07K19/00
- IPC: C07K19/00 ; C07K14/78 ; A61K45/06 ; C07K16/28 ; C07K14/705 ; C07K14/71 ; C07K14/47 ; A61K38/00 ; A61K39/00
Abstract:
Monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making thereof are useful in the generation of therapeutic molecules and treatment and diagnosis of diseases and disorders.
Public/Granted literature
- US20140155326A1 EGFR AND C-MET FIBRONECTIN TYPE III DOMAIN BINDING MOLECULES Public/Granted day:2014-06-05
Information query
